Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotracheal epinephrine for oxygenation in severe COVID-19
IRCT20210613051560N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epinephrine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Oxygen saturation. Started Dec 2021; status: completed.
02
Drugs
epinephrine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210613051560N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210613051560N1.